RSMC Rockefeller U.S. Small-Mid Cap ETF

Expense Ratio
0.75%
Previous close
$25.37
Est. 12 months change
+22.57%
Projected Price
$31.10

Profitability Metrics

Return on Equity (ROE)
14.30%
Return on Assets (ROA)
6.21%
Return on Invested Capital (ROIC)
12.82%
Weighted Average Cost of Capital (WACC)
9.09%
ROIC - WACC
3.73%
Updated : 2026-04-04 07:24 ET

Valuation Metrics

P/E Ratio
24.78
Forward P/E
19.53
PEG Ratio
7.05
Debt Current Ratio
2.44

Growth & Cash Flow

Gross Margin
43.87%
Operating Margin
2.81%
FCF Margin
14.40%
TTM Revenue Growth
13.38%
Projected 12M EPS Growth
26.90%

Price Change

Price % from 50 SMA
-1.59%
Price % from 200 SMA
-2.01%
6 Months
-3.22%
1 Year
4.90%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
FCFS4.68%
SNEX4.51%
HASI3.92%
BJ3.78%
BMI3.54%
RDNT3.20%
NA3.13%
ESE2.95%
ULS2.93%
LRN2.75%

ETF Analysis

Fund Overview

Rockefeller U.S. Small-Mid Cap ETF (RSMC) currently reports 45 stock positions (subject to change), placing it in the neither concentrated nor index-like range by holdings breadth. The top line-up is FCFS (4.68%), SNEX (4.51%), HASI (3.92%), with FCFS as the largest single weight at 4.68%. Together, the top three holdings account for 13.11%, which indicates that idiosyncratic risk at the top of the book is relatively contained within the overall portfolio. The resulting profile combines thematic conviction with varying degrees of diversification, which can support upside participation while still spreading idiosyncratic risk beyond the top weights.

Profitability & Capital Efficiency

From a returns-on-capital standpoint, ROIC is 12.82%, WACC is 9.09%, and the economic spread is 3.73%. On balance, the portfolio clears its capital cost hurdle modestly — value creation is present but not emphatic. Supporting metrics show ROE at 14.30% and ROA at 6.21%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that is value-creative but with less room for execution slippage.

Valuation

The current pricing of the underlying holdings reads trailing P/E of 24.78, forward P/E of 19.53, PEG of 7.05. The trailing-to-forward compression is moderate — supportive of valuation, but not a dramatic signal of earnings acceleration. The PEG reading here is above the range most value-oriented investors would find comfortable — the valuation requires a high degree of confidence in forward earnings delivery. The aggregate current ratio of 2.44 points to adequate liquidity across holdings. In aggregate, the valuation reads as fair to moderately stretched — leaving the investment case dependent on earnings execution rather than multiple expansion.

Margins & Cash Generation

On profitability at each income statement layer, gross margin sits at 43.87%, operating margin at 2.81%, and free cash flow margin at 14.40%. The portfolio's gross margins are solid, reflecting a reasonable balance between revenue realization and direct cost absorption. Operating margins are negligible or negative, which is typical of portfolios with heavy exposure to businesses still building toward profitability. Free cash flow margins are moderate, with a meaningful but not exceptional share of revenue converting to cash after capex. Taken together, the margin stack suggests quality that is uneven — some layers are more resilient than others, and that asymmetry matters under stress.

Growth & Forward Outlook

Looking at growth and market-implied direction, TTM revenue growth of 13.38% indicating top-line growth that is constructive without being speculative. At the same time, the estimated 12-month price change of 22.80%, where implied upside appears constructive but not aggressive. It's worth distinguishing between what businesses are actually delivering and what the market is being asked to believe about the next 12 months. Maintaining alignment between reported results and forward estimates is particularly important in periods where macro uncertainty is elevated. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

Putting the pieces together, this is a profile with genuine merit: the numbers support confidence in the forward case without requiring heroic assumptions.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.